Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting
26 January 2024
Medicines for Europe and its members are strongly concerned by the first judgement on the Supplementary Protection Certificate (SPC) manufacturing waiver issued by the Munich District Court, Germany in October 2023.
